A Study to Evaluate Renal Fibrosis Using MRI Techniques

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 2 months later Sep 2026 → Dec 2027
See other at-risk trials from Mayo Clinic

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Sep 2026 to Dec 2027 Show 4 more changesShow less
    • Study completion pushed from Dec 2026 to Dec 2028
    • Eligibility criteria expanded, about 25 words
    • Secondary endpoints: details revised at 2 of 2 entries
    • Publications: details revised at 1 of 1 entry
  2. Primary completion date: Sep 2025 to Sep 2026
    • Study completion date: Dec 2025 to Dec 2026
    v15
  3. Trial status: Recruiting to Active, Not Recruitingv14 Show 4 more changesShow less
    • Enrollment target: estimated 27 to confirmed 24
    • Primary completion date: Jun 2025 to Sep 2025
    • Study completion date: Sep 2025 to Dec 2025
    • Site details revised
  4. Re-verified, no change to tracked fieldsv13
  5. Primary completion date: Sep 2023 to Jun 2025
    • Study completion date: Sep 2023 to Sep 2025
    v12
Show 10 earlier versionsHide 10 earlier versions
  1. Enrollment target: 15 to 27
    • Primary completion date: Sep 1, 2023 to Sep 2023
    • Study completion date: Sep 1, 2024 to Sep 2023
    v11
  2. Re-verified, no change to tracked fieldsv10
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 1, 2021 to Oct 1, 2020
    • Site details revised
    v9
  4. Eligibility criteria shortened, about 4 wordsv8
  5. Eligibility criteria expanded, about 23 wordsv7
  6. Primary completion date: Sep 1, 2022 to Sep 1, 2023
    • Start date: Apr 1, 2021 to Aug 1, 2021
    • Study completion date: Sep 1, 2023 to Sep 1, 2024
    v6
  7. Start date: Mar 1, 2021 to Apr 1, 2021v5
  8. Start date: Jan 12, 2021 to Mar 1, 2021v4
  9. Start date: Nov 12, 2020 to Jan 12, 2021v3
  10. Start date: Sep 1, 2020 to Nov 12, 2020v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mayo Clinic
1,024 trials monitored
See 128 trials at risk
Hypertension
1,933 trials monitored
See 101 trials at risk
The purpose of this study is to evaluate whether or not an MRI technique (quantitative magnetization transfer or qMT) in narrowing human kidneys is feasible, reproducible, and predicts recovery.
Trial Details
NCT Number NCT04508049
Lead Sponsor Mayo Clinic
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions
(from sponsor)		 Hypertension, Renovascular
Related terms Hypertension
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov